Featured Companies
Green Hydrogen Pioneer, Quebec Innovative Materials, QIMC, QIMCF Rising Rapidly
AI Driving National Grid to the Brink, White Hydrogen might be the solution for Power Hungry Hyperscalers. The stock has risen dramatically!
Unmet Energy Demand forcing Data Centers to look for new alternative sources of energy.
QIMC trying to bridge the gap! The company has recently announcement a series of measures.
1. QIMC Accelerates Hydrogen-AI Strategy as Industry Activity Intensifies Along Nova Scotia Hydrogen Corridor
2. QIMC Expands Temiscamingue Natural Hydrogen Corridor, Strengthening Its Geology-to-AI Off-Grid Energy Strategy
3. QIMC Advances Its Nova Scotia Natural Hydrogen District with Completion of a Baseline Environmental Assessment at Eatonville
4. QIMC Adopts Shareholder Rights Plan to Enhance Shareholder Protection and Protect Long-Term Value
Stay tuned!
Sponsored Content, please read the disclaimer/disclosure. thanks!
Buy Sell Penny Stocks is an affiliated property of Daily Stock Deals.
About Daily Stock Deals
Daily Stock Deals helps emerging growth companies reach individual and institutional investors. Daily Stock Deals and its affiliates publish research reports, market analysis and daily stock picks to help investors make informed decisions and achieve their individual investment goals. Our Platform is supported by companies we profile on our network, therefore, our views are neither free of conflict, nor intended as advise to buy/sell any securities and we strongly urge you to read our TOS, Disclaimer/Disclosure and consult with qualified experts. If you would like to get your company featured on Daily Stock Deals network or have any questions, please feel free to contact the editor. This email address is being protected from spambots. You need JavaScript enabled to view it." target="_blank" rel="noreferrer noopener">This email address is being protected from spambots. You need JavaScript enabled to view it." target="_blank" rel="noreferrer noopener">This email address is being protected from spambots. You need JavaScript enabled to view it." target="_blank" rel="noreferrer noopener"> This e-mail address is being protected from spambots. You need JavaScript enabled to view it thanks!
Terra Clean Energy, TCEC, TCEFF: Positioned for the breakout.
Terra Clean Energy Corp.
CSE: TCEC | OTCQB: TCEFF | FSE: C900 Website: tcec.energy
Executive Summary
The global energy equation has changed. With the rise of AI, data centers, and electrification, demand for reliable, carbon-free baseload power is surging—and nuclear energy is the only scalable solution. Governments are responding. The U.S. has passed landmark legislation to accelerate domestic uranium production and secure the nuclear supply chain. Terra Clean Energy is positioned to benefit directly.
"We’re not speculating on policy—we’re aligned with it. Our assets are in the right jurisdictions, our team is built for execution, and our strategy is designed to deliver shareholder value" Greg Cameron, CEO, Terra Clean Energy.
Investment Highlights
-
6.9M lbs U308 inferred at South Falcon East, Athabasca Basin
-
Confirmed uranium mineralization in 6 of 7 drill holes (2025 program)
-
75 past-producing claims in Utah with surface readings up to 21,000 CPS
-
Earn-in model with real leverage—structured for shareholder value
-
Infrastructure-rich assets near mills, roads, and power
-
Direct exposure to U.S. uranium policy tailwinds
Leadership Built for Execution
-
Greg Cameron (CEO): 20+ years in capital markets, focused on value creation
-
Alex Klenman (Director): Uranium veteran with $18M+ raised for Basin projects
-
C. Trevor Perkins (VP Exploration): Proven geologist with Basin success
-
Brian Shine (CFO): CPA with deep financial strategy experience
-
Tony Wonnacott (Director): Securities lawyer with $1B+ in capital raised
-
Jordan Trimble (Technical Advisor): CEO of Skyharbour Resources
Strategic Positioning
-
Microcap valuation with real assets—high leverage to discovery
-
Dual jurisdiction exposure—Canada and U.S. uranium corridors
-
Infrastructure access—accelerated path to development
-
Clean energy tailwinds—AI-driven electricity demand is rewiring the grid
Editor, Buy Sell Penny Stocks
As you know, we make no recommendations, this is an opinion and outlook column. Always Remember my Company's Motto: It's Your Money, Invest Wisely! ©®
For timely, actionable and potentially profitable news, fearless and uncensored views:> sign up for FREE in 15 seconds
Always Keep an Eye on this space for major announcements!
Reminder: Free Membership enables immediate access to @TOP10STOCKS a great way to start your trading day.
Source: OxBridge Research, Daily Stock Deals, PennyStockIQ DailyStockShow.com
About Daily Stock Deals
Daily Stock Deals helps emerging growth companies reach individual and institutional investors. Daily Stock Deals and its affiliates publish research reports, market analysis and daily stock picks to help investors make informed decisions and achieve their individual investment goals. Our Platform is supported by companies we profile on our network, therefore, our views are neither free of conflict, nor intended as advise to buy/sell any securities and we strongly urge you to read our TOS, Disclaimer/Disclosure and consult with qualified experts. If you would like to get your company featured on Daily Stock Deals network or have any questions, please feel free to contact the editor. This email address is being protected from spambots. You need JavaScript enabled to view it." target="_blank" rel="noreferrer noopener">This email address is being protected from spambots. You need JavaScript enabled to view it." target="_blank" rel="noreferrer noopener">This email address is being protected from spambots. You need JavaScript enabled to view it." target="_blank" rel="noreferrer noopener"> This e-mail address is being protected from spambots. You need JavaScript enabled to view it thanks!
Daily Stock Deals is an affiliated/partner property, please read TOS/Disclaimer/Disclosure, thanks!
The Answer to China's Rare Earth Hegemony, Threat to National Security
Appia Rare Earths & Uranium, CSE: API, OTCQB: APAAF, Company Profile
Rare Earths can Protect Your Portfolio, Invest in the future tech, mobility, space and defense
Opinion & Outlook
The Tariff Turmoil is a reminder for investors who are worried about protecting their investments and thinking about how to profit from uncertain market conditions. Appia Rare Earths & Uranium (CSE: API, OTCQB: APAAF) provides an opportunity to position yourself to succeed. Appia has the potential to deliver twice as much compared to other companies in her peer group. Before we take a deeper dive into their assets and evaluate them vis a vis their neighbors and peers, let me share a few facts about the company.
Appia is one of the few companies that have two distinct classes of strategic assets that are deemed to be in the vital interest of the U.S. National Security to acquire, protect and preserve. Appia has easily accessible and commercially viable Rare Earths and Uranium.
Uranium has been enjoying the greatest boom due to multiple economic and environmental factors converging at the same time, then the sudden and wildly successful GPT-4 emergence has unleashed the demand for electricity likes of which the world has never seen before. The scale is enormous and the need is so great, let me share some stats so you can wrap your head around, A single Hyperscale Data Center consumes as much electricity as a North American city of 250,000 residents. There is no way to meet such a demand without nuclear energy, therefore, more nuclear plants coming online and are being built than ever before, a great nuclear Renaissance is underway.
Appia's Uranium assets, located in a proven, highly prolific zone that boasts one of the largest uranium reserves in the world, are attracting inbound interest and the company is actively looking to develop the Uranium assets alone or in a partnership.
Rare Earths
Rare Earths are the crown Jewels of Appia, these high value assets are strategically located in a safe jurisdiction near a large population, among its many strategic advantage are an easy access to material and much needed skilled manpower, industrial grade utilities and transportation infrastructure, we estimate that the ease of access to labor and infrastructure, and avoiding the hassle of seeking permits from various local government institutions are worth millions of dollars in savings for the Company.
The district scale mega Rare Earth Project with its unique geology, high purity metal and easily extractable clay combined with a proven DE technology is nothing short of a match made in heaven.
No other company possesses assets of this high quality in such a large quantity, which can be commercially exploited year-round due to the tropical climate, location and safe jurisdiction.
Medium/Long Term Value
The insatiable hunger for rare earths is growing at double digits and is expected to grow even faster as we continue to electrify our transportation systems to meet the 2035 Zero Carbon Goals. Robotics, Quantum computing and Proliferation of Consumer Electronic Gadgets will further increase future demand for rare earths by a magnitude.
Appia is hugely undervalued, and the company's extremely underappreciated assets are poised to regain their full valuation as the company completes the PEA then embarks on commercial production of these highly valuable, strategically significant rare earths away from the Chinese Orbit.
We believe that this is a great time to own a highly valuable asset that's selling for under 10 cents on a dollar. We think you should ask your financial advisor if Appia is right for you!
Editor, Buy Sell Penny Stocks
As you know, we make no recommendations, this is an opinion and outlook column. Always Remember my Company's Motto: It's Your Money, Invest Wisely! ©®
For timely, actionable and potentially profitable news, fearless and uncensored views:> sign up for FREE in 15 seconds
Always Keep an Eye on this space for major announcements!
Reminder: Free Membership enables immediate access to @TOP10STOCKS a great way to start your trading day.
Source: OxBridge Research, Daily Stock Deals, PennyStockIQ DailyStockShow.com
About Daily Stock Deals
Daily Stock Deals helps emerging growth companies reach individual and institutional investors. Daily Stock Deals and its affiliates publish research reports, market analysis and daily stock picks to help investors make informed decisions and achieve their individual investment goals. Our Platform is supported by companies we profile on our network, therefore, our views are neither free of conflict, nor intended as advise to buy/sell any securities and we strongly urge you to read our TOS, Disclaimer/Disclosure and consult with qualified experts. If you would like to get your company featured on Daily Stock Deals network or have any questions, please feel free to contact the editor. This email address is being protected from spambots. You need JavaScript enabled to view it." target="_blank" rel="noreferrer noopener">This email address is being protected from spambots. You need JavaScript enabled to view it." target="_blank" rel="noreferrer noopener">This email address is being protected from spambots. You need JavaScript enabled to view it." target="_blank" rel="noreferrer noopener"> This e-mail address is being protected from spambots. You need JavaScript enabled to view it thanks!
Daily Stock Deals is an affiliated/partner property, please read TOS/Disclaimer/Disclosure, thanks!
White Gold Rush, Natural Hydrogen, Zero Carbon Fuel that never depletes
Quebec Innovative Materials, Company Profile, Stock Summary
Quebec Innovative Materials is a mineral exploration and development company with a portfolio of natural resource assets including high grade silica, hydrogen, and helium properties. QIMC is working toward becoming a sustainable supplier of resources which are essential in the electrification of the green economy. Hydrogen is a Zero tailpipe emission alternative fuel.
The Company has a 100% interest in:
• The Charlevoix Silica Project, near Clermont, Quebec, Canada
• The River Valley Silica Project, near Sudbury, Ontario, Canada
• The Ville Marie Hydrogen project in the Temiscamingue area of Quebec
PROJECTS
♥ Charlevoix Silica Project, Quebec, Canada - Industrial Minerals
♥ River Valley Silica Property, Ontario, Canada - Industrial Minerals
♥ Ville Marie Hydrogen Property, Quebec, Canada - Hydrogen & Helium
VILLE MARIE PROPERTY
Industrial Minerals Temiscaming property with unique geology also prospective for naturally occurring hydrogen and helium.
Stage: Follow up on recent field work and sampling
Ownership: 100% owned by QI Materials
Location: Mining friendly province of Quebec
Access: 15 km north of the town of Ville Marie, located between two major mining cities.
The Temiscamingue graben area is severely affected by seismicity and normal faults related to extensional processes are still active today (Fig. below). Such structures may be important in allowing the transfer of gases from deep sources to shallow environments. For H2 and He exploration, these faults must be well located in space (Lidar, AMT, gravity, magnetometric surveys) and geophysical surveys must be carried out to verify the vertical extension (in depth) of the faults. The deeper these structures are, the greater the potential for gas transfer.
VILLE MARIE PROPERTY
QI Materials Témiscamingue property offers similar geology to
the recent large natural hydrogen Ramsey Project discovery
by GoldHydrogen Ltd in South Australia.
Comparable to Ramsey Project in Australia
Located at the Gawler craton of South Australia, where radiolysis and hydrolysis reactions of iron-rich rocks are ongoing creating naturally occurring hydrogen.
The Cambrian stratigraphy including tight limestones that overlie the basement source rocks provides likely seals that were penetrated by the historic wells that found hydrogen.
Ramsay Project is located on a major lithospheric boundary and bend in the Tasman line of the Delamerian orogeny. Additionally, it is within the setting of the tectonically active horst-graben Adelaide extensional rift.
ABOUT HYDROGEN
Global demand for natural hydrogen is accelerating as the world rapidly transitions to a decarbonized economy. Natural hydrogen is hydrogen that is formed by natural processes and has the potential to be the fuel of the future. It’s light, storable, energy-dense, and can be developed to provide clean energy.
° Significant cost and emissions advantages
° Accumulates naturally underground, generated by geological processes.
° Small exploration footprint with minimal environmental impact.
° Hydrogen is expected to play a key role in decarbonizing energy intensive industries.
ABOUT SILICA
• Cost effective.
• Most abundant element in earth’s crust after oxygen.
• Raw Silicon must be transformed and/or engineered before it can be used for battery Applications.
• Widely considered the next significant advance in battery technology as the theoretical charge capacity can be about 9X that of a typical graphite anode.
• Global silica sand market size is projected to grow from $11.29 billion in 2022 to $18.98 billion by 2029
• New plants are needed to meet demand growth.
• Growth will be driven by demand for chemical grade silicon (2N + Si).
Breakthroughs in utilizing metallurgical silicon for lithium-ion batteries show promise in addressing raw material scarcity and reducing costs in the EV sector. This innovation holds significant implications, potentially reshaping the industry's landscape toward affordable electric mobility.
About Daily Stock Deals
Daily Stock Deals helps emerging growth companies reach individual and institutional investors. Daily Stock Deals and its affiliates publish research reports, market analysis and daily stock picks to help investors make informed decisions and achieve their individual investment goals. Our Platform is supported by companies we profile on our network, therefore, our views are neither free of conflict, nor intended as advise to buy/sell any securities and we strongly urge you to read our TOS, Disclaimer/Disclosure and consult with qualified experts. If you would like to get your company featured on Daily Stock Deals network or have any questions, please feel free to contact the editor. This email address is being protected from spambots. You need JavaScript enabled to view it." target="_blank" rel="noreferrer noopener">This email address is being protected from spambots. You need JavaScript enabled to view it." target="_blank" rel="noreferrer noopener">This email address is being protected from spambots. You need JavaScript enabled to view it." target="_blank" rel="noreferrer noopener"> This e-mail address is being protected from spambots. You need JavaScript enabled to view it thanks!
Daily Stock Deals is an affiliated/partner property, please read TOS/Disclaimer/Disclosure, thanks!
BioCryst, BCRX, Company Profile, Stock Summary
BioCryst may be a buy, BCRX Bouncing back, still at 50% Discount, Insiders Buying
BioCryst is a commercial-stage biotech company that is committed to delivering extraordinary medicines that help patients live ordinary lives. BioCryst is passionate about advancing novel therapeutics for patients with rare and serious diseases.
BioCryst’s US headquarters is located in Durham, North Carolina, our European headquarters in Dublin, Ireland and our Discovery Center of Excellence in Birmingham, Alabama. With expertise in drug discovery, clinical development, and regulatory affairs, we are advancing clinical programs and generating new compounds from own discovery engine.
BioCryst Pharmaceuticals discovers novel, oral, small-molecule medicines that treat rare diseases in which significant unmet medical needs exist and
an enzyme plays a key role in the biological pathway of the disease. Oral, once-daily ORLADEYO® (berotralstat) is approved in the United States, the
European Union, Japan, the United Kingdom and the United Arab Emirates.
Insiders Buying vs Selling Ratio 2:1
We have noticed a bullish behavior from insiders, a number of insiders bought the stock in the past 12 months, the ratio was about 2 to 1.
European Medicines Agency grants access to PRIME
European Medicines Agency (EMA) has granted access to the Priority Medicines (PRIME) scheme for BCX9250, a novel, oral activin receptor-like kinase-2 (ALK-2) inhibitor discovered and developed by BioCryst for the treatment of fibrodysplasia ossificans progressiva (FOP).
PRIME is a program launched by the EMA to enhance support for the development of medicines that target an unmet medical need. This voluntary program is based on enhanced interaction and early dialogue with developers of promising medicines and is designed to optimize development plans and speed up evaluation so these medicines can potentially reach patients earlier. According to the EMA, developers of medicines that are eligible for PRIME can expect additional opportunities for scientific advice and be eligible for accelerated assessment at the time of application for a marketing authorization.
“Promising results from non-clinical data and the first-in-human Phase 1 safety, tolerability and pharmacokinetics study in healthy subjects formed the basis of the application for PRIME eligibility. We are pleased with the EMA’s decision to grant PRIME eligibility to BCX9250 – the first investigational drug for this indication to receive this designation – based on the early evidence of the potential of BCX9250 to address the unmet need for patients living with FOP. We look forward to applying the benefits available to us through PRIME as we continue to advance our ALK-2 inhibitor program,” said Dr. Helen Thackray, chief research and development officer of BioCryst.
FOP is an ultra-rare, severely disabling genetic disorder characterized by the irregular formation of bone outside the normal skeleton, also known as heterotopic ossification (HO). HO can occur in muscles, tendons, ligaments and other connective tissues. Patients with FOP become bound by this irregular ossification over time, with restricted movement and fused joints, resulting in deformities, restricted mobility and premature mortality.
BCX9250 is designed to inhibit the ALK-2 enzyme, which is a part of the normal signaling pathway for bone formation and responds to binding its specific ligands (bone morphogenic proteins, BMPs) by stimulating normal bone growth and renewal in healthy children and adults. Specific activating mutations of the ALK-2 gene are seen in all cases of FOP. An activating mutation in ALK-2 is necessary for the disease to occur, making the ALK-2 enzyme an ideal drug target for treatment of FOP.
The Company has several ongoing trails at various stages
BioCryst has several ongoing development programs including BCX9930,
an oral Factor D inhibitor for the treatment of complement-mediated diseases, BCX9250, an ALK-2 inhibitor for the treatment of fibrodysplasia
ossificans progressiva, and galidesivir, a potential treatment for Marburg virus disease and Yellow Fever.
RAPIVAB® (peramivir injection) has received regulatory approval in the U.S., Canada, Australia, Japan, Taiwan and Korea.
Editor, Daily Stock Deals
For timely, actionable and potentially profitable news and uncensored views:> sign up for FREE in 15 seconds
Keep an eye on this space for major announcements!
Reminder: Free Membership enables immediate access to @TOP10STOCKS a great way to start your trading day
Source: The Company, OxBridge Research, Daily Stock Deals, PennyStockIQ
Feed Entries
